Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Total 13F shares
-
118,378,841
-
Share change
-
+19,715,955
-
Total reported value
-
$121,933,794
-
Put/Call ratio
-
52%
-
Price per share
-
$1.03
-
Number of holders
-
138
-
Value change
-
+$19,988,838
-
Number of buys
-
50
-
Number of sells
-
57
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q3 2023
As of 30 Sep 2023,
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) was held by
138 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
118,378,841 shares.
The largest 10 holders included
Rubric Capital Management LP, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, BlackRock Inc., Velan Capital Investment Management LP, FRANKLIN RESOURCES INC, JPMORGAN CHASE & CO, Clearline Capital LP, GREAT POINT PARTNERS LLC, and PALISADE CAPITAL MANAGEMENT, LP.
This page lists
138
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.